Our study’s sample size was considered adequate to detect CAD with high talin-1 (>0.28 ng/mL) by statistical power of 80% and α-value of 0.05, since 307 patients were determined to be an adequate size. This evidence concerns the gene TLN1 and coronary artery disorder.